Gilead to pay $11.9B for cancer treatment developer Kite
Gilead Sciences will pay $11.9 billion in cash to buy Kite Pharma and plant a stake in an emerging area ...
Gilead Sciences will pay $11.9 billion in cash to buy Kite Pharma and plant a stake in an emerging area ...